American Journal of Cardiology
Volume 103, Issue 7 , Pages 954-958 , 1 April 2009

Impact of Admission Glucose Level and Presence of Diabetes Mellitus on Mortality in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Treated Conservatively

  • Artur Dziewierz, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Dawid Giszterowicz, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Zbigniew Siudak, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Tomasz Rakowski, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Waldemar Mielecki, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Marcin Suska, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Jacek S. Dubiel, MD

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Dariusz Dudek, MD

      Affiliations

    • Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • Corresponding Author InformationCorresponding author: Tel: 48-12-424-7181; fax: 48-12-424-7184

Received 3 August 2008 ,Revised 1 December 2008 ,Accepted 1 December 2008.

References 

  1. Dudek D, Siudak Z, Kuta M, Dziewierz A, Mielecki W, Rakowski T, et al. Management of myocardial infarction with ST-segment elevation in district hospitals without catheterisation laboratory—Acute Coronary Syndromes Registry of Malopolska 2002–2003. Kardiol Pol. 2006;64:1053–1060
  2. Dziewierz A, Siudak Z, Rakowski T, Mielecki W, Giszterowicz D, Dubiel JS, et al. More aggressive pharmacological treatment may improve clinical outcome in patients with non–ST-elevation acute coronary syndromes treated conservatively. Coron Artery Dis. 2007;18:299–303
  3. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384–416
  4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778
  5. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078–3086
  6. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;117:1610–1619
  7. Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;45:999–1002
  8. Undas A, Wiek I, Stepien E, Zmudka K, Tracz W. Hyperglycemia is associated with enhanced thrombin formation, platelet activation and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care. 2008;31:1590–1595
  9. Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol. 2003;41:1013–1020
  10. Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, et al. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non–ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J. 2007;28:806–813
  11. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus: DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314:1512–1515
  12. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626–2632
  13. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650–661
  14. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765–770
  15. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367
  16. Holmes DR, Berger PB, Hochman JS, Granger CB, Thompson TD, Califf RM, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation. 1999;100:2067–2073
  17. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598–1660
  18. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol. 2007;99:636–641
  19. Dudek D, Chyrchel B, Siudak Z, Depukat R, Chyrchel M, Dziewierz A, et al. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score. Kardiol Pol. 2008;66:28–34
  20. Yan AT, Yan RT, Tan M, Constance C, Lauzon C, Zaltzman J, et al. Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes. Can J Cardiol. 2006;22:115–120

PII: S0002-9149(08)02175-9

doi: 10.1016/j.amjcard.2008.12.008

American Journal of Cardiology
Volume 103, Issue 7 , Pages 954-958 , 1 April 2009

Article Tools

* Image Usage & Resolution